An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
Maria C. Ferrández(Cancer Center Amsterdam), Ronald Boellaard(Amsterdam Neuroscience), Sándor Czibor(Semmelweis University), Martijn W. Heymans(Amsterdam Neuroscience), Martine E.D. Chamuleau(Hovon), G. Mikhaeel(Guy's and St Thomas' NHS Foundation Trust), Tamás Györke(Semmelweis University), Bart M. de Vries(Dutch Cancer Society), Sze Ting Lee(Amsterdam University Medical Centers), Luca Ceriani(St Thomas' Hospital), Lars Kurch, Lale Kostakoğlu, Coreline N. Burggraaff(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jakoba J. Eertink(Amsterdam Neuroscience), Simone Pieplenbosch(Dutch Cancer Society), Sally F. Barrington(King's College London), Stefano Fanti(Azienda USL di Bologna), Martin Hutchings(University of Copenhagen), Josée M. Zijlstra(Amsterdam University Medical Centers), Pieternella J. Lugtenburg(Erasmus MC Cancer Institute), Sandeep S.V. Golla(Dutch Cancer Society), Gerben J.C. Zwezerijnen(Amsterdam Neuroscience), Sanne E. Wiegers(Dutch Cancer Society), Yvonne W. S. Jauw(Dutch Cancer Society), Andreas Hüttmann(University of Duisburg-Essen), Ulrich Dührsen(Essen University Hospital), Otto S. Hoekstra(Amsterdam Neuroscience), Robert Carr(Semmelweis University), Emanuele Zucca(Università della Svizzera italiana), Annika Loft(Rigshospitalet), Henrica C. W. de Vet(Amsterdam University Medical Centers), Annelies Bes(Amsterdam University Medical Centers), Christine Hanoun(Essen University Hospital)
Cited by 34
Related Papers
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
|Journal of Clinical Oncology|2014|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|578
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573